Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Ko-Chung Lin"'
Autor:
Yi‐Wen Huang, Albert Qin, Jane Fang, Ting‐Fang Wang, Chung‐Wei Tsai, Ko‐Chung Lin, Ching‐Leou Teng, Richard Larouche
Publikováno v:
British Journal of Clinical Pharmacology. 88:2396-2407
Ropeginterferon alfa-2b is a novel, long-acting pegylated interferon alfa-2b. We aimed to evaluate its safety, pharmacokinetics (PK) and pharmacodynamics (PD).Thirty-six subjects received single subcutaneous injection of ropeginterferon alfa-2b at do
Autor:
Melissa Tam, Xiaowei Jin, Ko-Chung Lin, Jianbo Zhang, Patrick Conlon, Chi Vu, Liqing Chen, Glenn Smits, William F. Kiesman, Petter Russell C, Frank Lutterodt
Publikováno v:
Journal of Medicinal Chemistry. 49:7132-7139
Novel tricyclic imidazoline antagonists of the adenosine A1 receptor are described. For key compounds, the selectivity level over other adenosine receptor subtypes is examined along with their in vivo effects in a rat diuresis model. Compound 14, the
Autor:
Rex A. Palmer, Cuervo Julio Hernan, Zimmerman Craig N, Tapan K. Chattopadhyay, Juswinder Singh, Ko-Chung Lin, Wen-Cherng Lee, Michael Karpusas, Steven P. Adams, Humayun Saleem Ateeq, Hammond Charles E, Yu-Sheng Liao, Herman W. T. van Vlijmen
Publikováno v:
Journal of Computer-Aided Molecular Design. 16:201-211
The integrin VLA-4 (alpha4,beta1) is involved in the migration of white blood cells to sites of inflammation, and is implicated in the pathology of a variety of diseases including asthma and multiple sclerosis. We report the structure-activity relati
Publikováno v:
Biochemistry. 37:8743-8753
We have used chemical cross-linking to identify sequences in integrin alpha4beta1 that are involved in its interactions with ligands. A recently described leucine-aspartic acid-valine (LDV)-based small molecule inhibitor of alpha4beta1 (BIO-1494), th
Autor:
Darryl G. Cleary, Kenneth J. Gruys, James A. Sikorski, Joel E. Ream, Paul D. Pansegrau, Michael J. Miller, C. Y. Han, R. Douglas Sammons, Diane Susan Braccolino, Ko-Chung Lin, Karen S. Anderson
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 3:1435-1440
Studies using alternate substrates, inhibitor product mimics and new derivatives of 4,5-dideoxy-shikimate-3-phosphate (ddS3P) are reported which indicate that the 3-phosphate group contributes significantly to substrate and inhibitor recognition at t
Autor:
Kenneth J. Gruys, Michael J. Miller, C. Y. Han, Mark C. Walker, Dora M. Schnur, Ko-Chung Lin, Jose L. Font, Paul D. Pansegrau, Susan D. Corey, Diane Susan Braccolino, James A. Sikorski, Ajit S. Shah, D. G. Cleary, Joel E. Ream
Publikováno v:
Phosphorus, Sulfur, and Silicon and the Related Elements. 76:115-118
Novel aromatic bisubstrate inhibitors of the enzyme EPSP (5-enolpyruvoylshikimate-3-phosphate) synthase (EC 2.5.1.19) have been designed and synthesized as structural analogs of the single, catalytic intermediate 1 utilized by the enzyme. These aroma
Autor:
Michael J. Miller, C. Y. Han, Kenneth J. Gruys, James A. Sikorski, Ko-Chung Lin, Joel E. Ream, Paul D. Pansegrau, D. G. Cleary, Mark C. Walker, Diane Susan Braccolino, Dora M. Schnur, Jose L. Font, Susan D. Corey, Ajit S. Shah
Publikováno v:
ChemInform. 24
Novel aromatic bisubstrate inhibitors of the enzyme EPSP (5-enolpyruvoylshikimate-3-phosphate) synthase (EC 2.5.1.19) have been designed and synthesized as structural analogs of the single, catalytic intermediate 1 utilized by the enzyme. These aroma
Autor:
Mark Leuchtenberger, Pedro de Noronha Pissarra, C Mark Tang, Ko-Chung Lin, Pratik Shah, Fritz R. Bühler
Publikováno v:
Bioentrepreneur.
Many cities and countries still view the foundation of a biotech sector as desirable for a high-tech, intellectually driven economy. But a discussion by seasoned biotech management and investors suggests that attaining an environment with the right m
Autor:
Juswinder, Singh, Herman, van Vlijmen, Wen-Chemg, Lee, Yusheng, Liao, Ko-Chung, Lin, Humayun, Ateeq, Julio, Cuervo, Craig, Zimmerman, Charles, Hammond, Michael, Karpusas, Rex, Palmer, Tapan, Chattopadhyay, Steven P, Adams
Publikováno v:
Journal of computer-aided molecular design. 16(3)
The integrin VLA-4 (alpha4,beta1) is involved in the migration of white blood cells to sites of inflammation, and is implicated in the pathology of a variety of diseases including asthma and multiple sclerosis. We report the structure-activity relati
Autor:
Ashfaq Ahmed, Roy Lobb, Yelena Botinnikova, Ko-Chung Lin, Alan J. Gill, M. W. Sielczak, William M. Abraham, Diane R. Leone, Isabel T. Lauredo, Steven P. Adams, Blake Pepinsky
Publikováno v:
American journal of respiratory and critical care medicine. 162(2 Pt 1)
The leukocyte integrin very late antigen-4 (alpha(4)beta(1), CD49d/CD29) is an adhesion receptor that plays an important role in allergic inflammation and contributes to antigen-induced late responses (LAR) and airway hyperresponsiveness (AHR). In th